(Q35583393)

9 August 2017

1 reference

title

Update on genetic and clinical aspects of primary hyperparathyroidism (English)

1 reference

9 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

1 April 2024

author name string

S. Miedlich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616876

1 April 2024

K. Krohn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616876

1 April 2024

R. Paschke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616876

1 April 2024

language of work or name

1 reference

1 November 2003

1 reference

full work available at URL

9 August 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2265.2003.t01-1-01755.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616876

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2265.2003.t01-1-01755.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2265.2003.t01-1-01755.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

1 April 2024

published in

Clinical Endocrinology

1 reference

9 August 2017

59

1 reference

9 August 2017

5

1 reference

9 August 2017

539-554

1 reference

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

9 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

The extracellular calcium-sensing receptor: its role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Electrolyte quintet: Calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Positional cloning of the gene for multiple endocrine neoplasia-type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Menin, the product of the MEN1 gene, is a nuclear protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Patterns of chromosomal imbalances in parathyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Menin interacts directly with the homeobox-containing protein Pem

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Case-control study on symptoms and signs of "asymptomatic" primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Hyperparathyroid and hypoparathyroid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Actions of lithium on the cyclic AMP signalling system in various regions of the brain--possible relations to its psychotropic actions. A study on the adenylate cyclase in rat cerebral cortex, corpus striatum and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Prediction of bone density from vitamin D receptor alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

A novel cyclin encoded by a bcl1-linked candidate oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Calcimimetics with potent and selective activity on the parathyroid calcium receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

The effects of vitamin D insufficiency in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Antifracture efficacy of antiresorptive agents are related to changes in bone density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Comparative genomic hybridization analysis of human parathyroid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Thirteenth annual meeting of the American Society for Bone and Mineral Research. San Diego, California, August 24-28, 1991. Program and abstracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

How asymptomatic is asymptomatic primary hyperparathyroidism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Structural analysis of gene marker loci on chromosomes 10 and 11 in primary and secondary uraemic hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Parathyroid hormone gene polymorphisms in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Influence of minor ear surgery on infrared tympanic thermometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Clinical studies of multiple endocrine neoplasia type 1 (MEN1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Does estrogen replacement therapy influence parathyroid hormone responsiveness to exogenous hypercalcemia in postmenopausal women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.T01-1-01755.X

Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone

1 April 2024

2

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density

1 April 2024

3

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake

1 April 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

The Albert Lasker Medical Awards. Inositol trisphosphate, calcium, lithium, and cell signaling

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Primary hyperparathyroidism. When to observe and when to operate

1 April 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Intraoperative parathyroid hormone monitoring as an adjunct to parathyroidectomy

1 April 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women.

1 April 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

A Detailed Evaluation of Oral Phosphate Therapy in Selected Patients With Primary Hyperparathyroidism*

1 April 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Vitamin D receptor genotypes in primary hyperparathyroidism

1 April 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism

1 April 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor

1 April 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas.

1 April 2024

33

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Prevalence of hypercalcaemia in a health screening in Stockholm

1 April 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects

1 April 2024

37

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels

1 April 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Frequent loss of chromosome arm 1p DNA in parathyroid adenomas

1 April 2024

42

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3

1 April 2024

44

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report

1 April 2024

46

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Parathyroid carcinoma in familial hyperparathyroidism

1 April 2024

47

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?

1 April 2024

49

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Drug treatment of primary hyperparathyroidism: use of clodronate disodium

1 April 2024

50

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

The relationship of serum ionized and total calcium in primary hyperparathyroidism

1 April 2024

53

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

A comparative study of serum ultrafiltrable, ionized, and total calcium in the diagnosis of primary hyperparathyroidism in patients with intermittent or no elevation in total calcium

1 April 2024

59

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Familial parathyroid carcinoma

1 April 2024

60

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Genetic abnormalities in sporadic parathyroid adenomas

1 April 2024

61

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function

1 April 2024

62

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism.

1 April 2024

64

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Clodronate in the medical management of hyperparathyroidism

1 April 2024

70

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Asymptomatic primary hyperparathyroidism

1 April 2024

71

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Somatic mutation of the MEN1 gene in parathyroid tumours.

1 April 2024

73

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Role of genetic factors in the pathophysiology and management of osteoporosis

1 April 2024

76

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

A strategy for the management of elderly women with primary hyperparathyroidism: a comparison of etidronate therapy with parathyroidectomy

1 April 2024

77

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.

1 April 2024

78

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.

1 April 2024

83

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Regulation by calcium and 1,25-(OH)2D3 of cell proliferation and function of bovine parathyroid cells in culture

1 April 2024

86

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome

1 April 2024

87

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Primary hyperparathyroidism detected in a health screening. The Trømsø study

1 April 2024

88

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity

1 April 2024

89

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Familial primary hyperparathyroidism complicated with Wilms' tumor

1 April 2024

91

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Relationship between Ca-dependent change of serum PTH and extracellular Ca2+-sensing receptor expression in parathyroid adenoma.

1 April 2024

92

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism

1 April 2024

93

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells

1 April 2024

98

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Mutation and cancer: statistical study of retinoblastoma

1 April 2024

99

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Vitamin D receptor genotype is associated with cortical bone loss in Japanese patients with primary hyperparathyroidism.

1 April 2024

101

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells.

1 April 2024

103

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Familial hypocalciuric hypercalcaemia. II. Intestinal calcium absorption and vitamin D metabolism

1 April 2024

104

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Amelioration of postmenopausal primary hyperparathyroidism during adjuvant tamoxifen for breast cancer

1 April 2024

105

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Metabolism of 1,25-dihydroxyvitamin D3

1 April 2024

107

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Age-dependent genetic effects on a secondary sexual trait in male Alpine ibex, Capra ibex

1 April 2024

109

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Abnormal regulation of parathyroid cell secretion and proliferation in primary cultures of bovine parathyroid cells

1 April 2024

110

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism

1 April 2024

113

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Minimally invasive video-assisted parathyroidectomy: multiinstitutional study

1 April 2024

114

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy

1 April 2024

116

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Lithium effects on dispersed bovine parathyroid cells grown in tissue culture

1 April 2024

117

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Investigation of calcium-induced hydrolysis of phosphoinositides in normal and lithium-treated parathyroid cells

1 April 2024

118

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

The role of ionized calcium in the diagnosis of subtle hypercalcemia in symptomatic primary hyperparathyroidism

1 April 2024

120

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Cyclin D1 in parathyroid disease.

1 April 2024

121

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds

1 April 2024

124

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Minimally invasive surgery for thyroid and parathyroid diseases

1 April 2024

125

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism

1 April 2024

126

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Frequency of the calcium-sensing receptor variant A986S in patients with primary hyperparathyroidism

1 April 2024

127

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?

1 April 2024

128

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets

1 April 2024

129

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Video-assisted neck exploration for primary and secondary hyperparathyroidism: initial experience.

1 April 2024

133

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Dexamethasone-treated ROS 17/2.8 rat osteosarcoma cells are responsive to human carboxylterminal parathyroid hormone peptide hPTH (53-84): stimulation of alkaline phosphatase

1 April 2024

134

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients.

1 April 2024

135

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D

1 April 2024

136

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.

1 April 2024

137

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor

1 April 2024

139

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells

1 April 2024

140

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

BsmI vitamin D receptor polymorphism and pathogenesis of parathyroid adenoma

1 April 2024

144

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Novel Chromosomal Abnormalities Identified by Comparative Genomic Hybridization in Parathyroid Adenomas

1 April 2024

145

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings

1 April 2024

146

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values

1 April 2024

147

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Effects of transdermal estrogen replacement on parathyroid hormone secretion.

1 April 2024

149

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Lack of evidence for estrogen receptors in human and bovine parathyroid tissue.

1 April 2024

150

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Lithium-induced alterations in parathyroid cell function: insight into the pathogenesis of lithium-associated hyperparathyroidism

1 April 2024

151

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism

1 April 2024

154

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Parathyroid adenomas following irradiation

1 April 2024

156

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Direct regulation by calcium of cytoplasmic messenger ribonucleic acid coding for pre-proparathyroid hormone in isolated bovine parathyroid cells

1 April 2024

157

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Effects of lithium on the endocrine system: a review

1 April 2024

158

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Oestrogen, progesterone, and glucocorticoid receptors in normal and neoplastic parathyroid glands

1 April 2024

159

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women

1 April 2024

160

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Comparative analysis of clonality and pathology in primary and secondary hyperparathyroidism

1 April 2024

161

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Primary hyperparathyroidism: still evolving?

1 April 2024

164

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

The distribution of two different vitamin D receptor polymorphisms (BsmI and start codon) in primary hyperparathyroidism

1 April 2024

169

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.

1 April 2024

173

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Multiple Endocrine Neoplasia--Syndromes of the Twentieth Century

1 April 2024

175

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Reduction in the rate of inositol 1,4,5-trisphosphate synthesis in rat parotid acini by lithium

1 April 2024

177

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor

1 April 2024

180

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Tertiary hyperparathyroidism in X-linked hypophosphatemic rickets

1 April 2024

185

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism

1 April 2024

186

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism

1 April 2024

188

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.T01-1-01755.X

1 April 2024

Identifiers

1 reference

9 August 2017

1 reference